Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$0.43
+10.3%
$0.49
$0.35
$1.22
$27.02M1.39122,040 shs100,284 shs
Solana Company stock logo
HSDT
Solana
$1.82
+1.7%
$1.88
$1.19
$25.50
$106.26M1.03395,442 shs224,549 shs
PolyPid Ltd. stock logo
PYPD
PolyPid
$5.58
+11.2%
$4.70
$3.06
$5.58
$106.48M1.492,463 shs504,096 shs
The Beauty Health Company stock logo
SKIN
Beauty Health
$0.75
+4.0%
$0.71
$0.55
$2.69
$97.84M1.08917,187 shs657,646 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
0.00%+7.73%-15.03%-33.90%-62.50%
Solana Company stock logo
HSDT
Solana
0.00%+3.47%+40.94%-5.79%-81.02%
PolyPid Ltd. stock logo
PYPD
PolyPid
0.00%+5.68%+11.56%+18.40%+43.84%
The Beauty Health Company stock logo
SKIN
Beauty Health
0.00%+9.97%+19.45%-18.68%-70.01%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$0.43
+10.3%
$0.49
$0.35
$1.22
$27.02M1.39122,040 shs100,284 shs
Solana Company stock logo
HSDT
Solana
$1.82
+1.7%
$1.88
$1.19
$25.50
$106.26M1.03395,442 shs224,549 shs
PolyPid Ltd. stock logo
PYPD
PolyPid
$5.58
+11.2%
$4.70
$3.06
$5.58
$106.48M1.492,463 shs504,096 shs
The Beauty Health Company stock logo
SKIN
Beauty Health
$0.75
+4.0%
$0.71
$0.55
$2.69
$97.84M1.08917,187 shs657,646 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
0.00%+7.73%-15.03%-33.90%-62.50%
Solana Company stock logo
HSDT
Solana
0.00%+3.47%+40.94%-5.79%-81.02%
PolyPid Ltd. stock logo
PYPD
PolyPid
0.00%+5.68%+11.56%+18.40%+43.84%
The Beauty Health Company stock logo
SKIN
Beauty Health
0.00%+9.97%+19.45%-18.68%-70.01%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
2.00
Hold$5.381,150.00% Upside
Solana Company stock logo
HSDT
Solana
2.50
Moderate Buy$3.5092.31% Upside
PolyPid Ltd. stock logo
PYPD
PolyPid
2.60
Moderate Buy$11.67109.08% Upside
The Beauty Health Company stock logo
SKIN
Beauty Health
2.00
Hold$2.02167.59% Upside

Current Analyst Ratings Breakdown

Latest CTSO, PYPD, HSDT, and SKIN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2026
The Beauty Health Company stock logo
SKIN
Beauty Health
Reiterated RatingSell (E+)
6/23/2026
PolyPid Ltd. stock logo
PYPD
PolyPid
UpgradeSell (E+)Sell (D-)
5/20/2026
The Beauty Health Company stock logo
SKIN
Beauty Health
Reiterated RatingBuy$2.50 ➝ $2.00
5/1/2026
PolyPid Ltd. stock logo
PYPD
PolyPid
DowngradeSell (D-)Sell (E+)
5/1/2026
The Beauty Health Company stock logo
SKIN
Beauty Health
Lower Price TargetHold$1.50 ➝ $1.00
4/27/2026
Solana Company stock logo
HSDT
Solana
UpgradeHold
4/23/2026
Solana Company stock logo
HSDT
Solana
Initiated CoverageBuy$3.00
4/22/2026
Solana Company stock logo
HSDT
Solana
UpgradeStrong-Buy
4/21/2026
Solana Company stock logo
HSDT
Solana
Reiterated RatingSell (E+)
4/8/2026
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
Reiterated RatingSell (E+)
4/6/2026
Solana Company stock logo
HSDT
Solana
Initiated CoverageHoldBuy$4.00
(Data available from 7/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$37.06M0.73N/AN/A$0.09 per share4.78
Solana Company stock logo
HSDT
Solana
$9.59M11.08N/AN/A$6.88 per share0.26
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/A$0.69 per shareN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
$296.12M0.33$0.16 per share4.75$0.48 per share1.57
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$8.20M-$0.19N/A14.33N/A-31.85%-235.57%-37.88%8/6/2026 (Estimated)
Solana Company stock logo
HSDT
Solana
-$40.89M-$109.67N/AN/AN/A-1,427.15%-67.57%-24.09%8/13/2026 (Estimated)
PolyPid Ltd. stock logo
PYPD
PolyPid
-$34.17M-$1.91N/AN/AN/AN/A-241.96%-126.91%8/12/2026 (Estimated)
The Beauty Health Company stock logo
SKIN
Beauty Health
-$9.52M-$0.17N/AN/AN/A-2.03%-9.38%-1.21%8/6/2026 (Estimated)

Latest CTSO, PYPD, HSDT, and SKIN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026
Solana Company stock logo
HSDT
Solana
-$0.34-$1.30-$0.96-$1.30$3.40 million$3.62 million
5/13/2026Q1 2026
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$0.06-$0.08-$0.02-$0.08$9.40 million$8.86 million
5/13/2026Q1 2026
PolyPid Ltd. stock logo
PYPD
PolyPid
-$0.47-$0.35+$0.12$0.35N/AN/A
5/7/2026Q1 2026
The Beauty Health Company stock logo
SKIN
Beauty Health
-$0.09-$0.05+$0.04-$0.05$66.28 million$64.91 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
N/AN/AN/AN/AN/A
Solana Company stock logo
HSDT
Solana
N/AN/AN/AN/AN/A
PolyPid Ltd. stock logo
PYPD
PolyPid
N/AN/AN/AN/AN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
4.70
1.09
0.81
Solana Company stock logo
HSDT
Solana
N/A
9.90
9.90
PolyPid Ltd. stock logo
PYPD
PolyPid
N/A
1.78
1.78
The Beauty Health Company stock logo
SKIN
Beauty Health
4.37
1.79
1.48

Institutional Ownership

CompanyInstitutional Ownership
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
32.87%
Solana Company stock logo
HSDT
Solana
18.63%
PolyPid Ltd. stock logo
PYPD
PolyPid
26.47%
The Beauty Health Company stock logo
SKIN
Beauty Health
93.26%

Insider Ownership

CompanyInsider Ownership
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
7.80%
Solana Company stock logo
HSDT
Solana
14.40%
PolyPid Ltd. stock logo
PYPD
PolyPid
24.70%
The Beauty Health Company stock logo
SKIN
Beauty Health
40.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
22062.84 million57.94 millionOptionable
Solana Company stock logo
HSDT
Solana
3058.39 million49.98 millionNot Optionable
PolyPid Ltd. stock logo
PYPD
PolyPid
8019.08 million14.37 millionNo Data
The Beauty Health Company stock logo
SKIN
Beauty Health
1,030129.60 million77.37 millionOptionable

Recent News About These Companies

The myth about glass skin

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cytosorbents stock logo

Cytosorbents NASDAQ:CTSO

$0.43 +0.04 (+10.26%)
Closing price 04:00 PM Eastern
Extended Trading
$0.42 -0.01 (-2.33%)
As of 06:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Solana stock logo

Solana NASDAQ:HSDT

$1.82 +0.03 (+1.68%)
Closing price 04:00 PM Eastern
Extended Trading
$1.86 +0.03 (+1.92%)
As of 06:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

PolyPid stock logo

PolyPid NASDAQ:PYPD

$5.58 +0.56 (+11.16%)
Closing price 04:00 PM Eastern
Extended Trading
$5.62 +0.04 (+0.79%)
As of 06:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Beauty Health stock logo

Beauty Health NASDAQ:SKIN

$0.75 +0.03 (+4.01%)
Closing price 04:00 PM Eastern
Extended Trading
$0.74 -0.01 (-1.84%)
As of 04:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.